Price caps and patient care. Drugmakers and hospital operators have cautioned that any pricing intervention must balance patient access with the financial sustainability of companies and healthcare providers. NPPA caps margins at 30% on 137 anti-cancer drugs from Nov 9, potentially cutting prices by 70%. Experts stress strict enforcement, transparent pricing and steady supplies to ensure patient savings.